Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 99 | 2022 |
Brucella arteritis: clinical manifestations, treatment, and prognosis JA Herrick, RJ Lederman, B Sullivan, JH Powers, TN Palmore The Lancet infectious diseases 14 (6), 520-526, 2014 | 80 | 2014 |
Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection PM Drame, DL Fink, J Kamgno, JA Herrick, TB Nutman Journal of clinical microbiology 52 (6), 2071-2077, 2014 | 68 | 2014 |
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials C Axfors, P Janiaud, AM Schmitt, J van’t Hooft, ER Smith, NA Haber, ... BMC infectious diseases 21, 1-23, 2021 | 61 | 2021 |
Eosinophil-Associated Processes Underlie Differences in Clinical Presentation of Loiasis Between Temporary Residents and Those Indigenous to Loa-Endemic … JA Herrick, S Metenou, MA Makiya, CA Taylar-Williams, MA Law, ... Clinical Infectious Diseases 60 (1), 55-63, 2015 | 47 | 2015 |
Inflammation is a key risk factor for persistent seizures in neurocysticercosis JA Herrick, B Maharathi, JS Kim, GG Abundis, A Garg, I Gonzales, ... Annals of clinical and translational neurology 5 (5), 630-639, 2018 | 34 | 2018 |
Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection JA Herrick, F Legrand, R Gounoue, G Nchinda, C Montavon, J Bopda, ... Clinical Infectious Diseases 64 (8), 1017-1025, 2017 | 31 | 2017 |
Identification and Validation of Loa loa Microfilaria-Specific Biomarkers: a Rational Design Approach Using Proteomics and Novel Immunoassays PM Drame, Z Meng, S Bennuru, JA Herrick, TD Veenstra, TB Nutman MBio 7 (1), 10.1128/mbio. 02132-15, 2016 | 28 | 2016 |
Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins MA Makiya, JA Herrick, P Khoury, CP Prussin, TB Nutman, AD Klion Journal of immunological methods 411, 11-22, 2014 | 26 | 2014 |
Unique characteristics of epilepsy development in neurocysticercosis JA Herrick, JA Bustos, P Clapham, HH Garcia, JA Loeb, ... The American Journal of Tropical Medicine and Hygiene 103 (2), 639, 2020 | 22 | 2020 |
Parasitic infections represent a significant health threat among recent immigrants in Chicago JA Herrick, M Nordstrom, P Maloney, M Rodriguez, K Naceanceno, ... Parasitology research 119, 1139-1148, 2020 | 16 | 2020 |
Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa JA Herrick, MA Makiya, N Holland-Thomas, AD Klion, TB Nutman Clinical Infectious Diseases 72 (5), 789-796, 2021 | 11 | 2021 |
A randomized, placebo-controlled, double-blind pilot study of single-dose humanized anti-IL5 antibody (reslizumab) for the reduction of eosinophilia following … F Legrand, J Herrick, M Makiya, R Ramanathan, R Thompson, ... Clinical Infectious Diseases 73 (7), e1624-e1631, 2021 | 10 | 2021 |
For The Cysticercosis Working Group In, P. Unique characteristics of epilepsy development in neurocysticercosis JA Herrick, JA Bustos, P Clapham, HH Garcia, JA Loeb Am J Trop Med Hyg 103 (2), 639-45, 2020 | 6 | 2020 |
Diagnosis and Management of Wound Infections AJM Lora, JA Herrick, B Recht, I Murphy-Aguilu Critical Limb Ischemia: Acute and Chronic, 517-530, 2017 | 1 | 2017 |
1327. The Diagnosis of Subarachnoid Neurocysticercosis Is Often Delayed And Other Findings of a Multicenter Retrospective in the USA JJ Guzmán, JA Herrick, T Hatlen, JE Weatherhead, E Clark, J Serpa, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1165, 2023 | | 2023 |
Association of substance use with outcomes in mildly ill COVID-19 outpatients R Pobee, T Cable, D Chan, J Herrick, V Durkalski-Mauldin, F Korley, ... The American journal of emergency medicine 74, 27-31, 2023 | | 2023 |
Comorbidity and Worse Outcome in Mildly Ill COVID-19 Outpatients R Pobee, T Cable, D Chan, J Herrick, F Korley, C Callaway, M Del-Rios Journal of the Academy of Nutrition and Dietetics 123 (9), A25, 2023 | | 2023 |
P12-018-23 Relationship Between Social Habits and Worse Outcome in Mildly Ill COVID-19 Outpatients R Pobee, M Del Rios, T Cable, D Chan, J Herrick, F Korley, C Callaway Current Developments in Nutrition 7, 2023 | | 2023 |
Diagnosis of Indolent Clonorchis sinensis and Opisthorchis viverrini Infections as Risk Factors for Cholangiocarcinoma: An Unmet Medical Need JA Herrick, I Rubinstein Federal Practitioner 40 (Suppl 1), S15, 2023 | | 2023 |